acute myelogenous leukemia
Showing NaN - NaN of 60
Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in
Terminated
- Acute Myelogenous Leukemia in Relapse
- +4 more
-
Tucson, Arizona
- +12 more
Aug 18, 2022
Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))
Completed
- Acute Myelogenous Leukemia
- Decitabine
- +4 more
-
Los Angeles, California
- +32 more
Jun 22, 2022
Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,
Terminated
- Related Donors Donating PBSC to a Family Member
- +4 more
- MGTA-145
- Plerixafor
-
Duarte, California
- +7 more
Apr 13, 2022
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Emavusertib
- +2 more
-
Tampa, Florida
- +8 more
Apr 5, 2022
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,
Terminated
- Acute Myelogenous Leukemia
- +2 more
- Fenretinide
- +2 more
-
Oklahoma City, Oklahoma
- +1 more
Mar 17, 2022
Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United
Completed
- Acute Myelogenous Leukemia
- +3 more
- XmAb14045
-
Jacksonville, Florida
- +8 more
Mar 4, 2022
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- FT-2102 (olutasidenib)
- +2 more
-
Los Angeles, California
- +59 more
Mar 2, 2022
Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional
Active, not recruiting
- Acute Myeloid Leukemia
- +8 more
- Iomab-B
- +2 more
-
Gilbert, Arizona
- +23 more
Feb 22, 2022
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (Milademetan, AZA)
Terminated
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
Duarte, California
- +4 more
Sep 14, 2021
Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)
Active, not recruiting
- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
- MCLA-117 bispecific antibody
-
Augusta, Georgia
- +9 more
May 6, 2021
Acute Myelogenous Leukemia Trial in United States (KIR genotype)
Completed
- Acute Myelogenous Leukemia
- KIR genotype
-
Scottsdale, Arizona
- +18 more
Mar 9, 2021
Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,
Terminated
- Double Cord Blood Transplant
- +8 more
- TXA127 300 mcg/kg/day
- TXA127 1000 mcg/kg/day
-
Houston, TexasMD Anderson Cancer Center
Dec 7, 2020
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC
Completed
- Acute Myelogenous Leukemia
- +3 more
- Infusion of one MPC expanded cord unit and one unexpanded cord unit
- Infusion of two unexpanded cord blood units.
-
Miami, Florida
- +8 more
Jun 25, 2020
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Tetanus)
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- Tetanus
-
Houston, Texas
- +1 more
Apr 20, 2020
Acute Myelogenous Leukemia Trial in Houston (Plerixafor, Clofarabine)
Terminated
- Acute Myelogenous Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 19, 2019
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (FT-1101, Azacitidine)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Los Angeles, California
- +7 more
Jun 25, 2019
Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in Houston (Decitabine, Valproic Acid)
Completed
- Myelodysplastic Syndrome
- Acute Myelogenous Leukemia
- Decitabine
- Valproic Acid
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 2, 2019
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (BVD-523)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
Los Angeles, California
- +4 more
Jan 9, 2019
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Gelonin, Busulfan, Fludarabine)
Terminated
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Gelonin
- +2 more
-
Houston, TexasUT MD Anderson Cancer Center
Oct 30, 2018
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Leukemia Trial in Houston (Procrit)
Completed
- Acute Myelogenous Leukemia
- +2 more
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
May 1, 2018
Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in United States (Standard dose cytarabine for induction, SGN-CD33A,
Completed
- Acute Myeloid Leukemia
- Acute Myelogenous Leukemia
- Standard dose cytarabine for induction
- +3 more
-
Birmingham, Alabama
- +12 more
May 8, 2018
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, B-cell Chronic Lymphocytic Leukemia Trial in Scottsdale, Atlanta,
Completed
- Acute Lymphoblastic Leukemia
- +4 more
- ABT-348
- ABT-348 and azacitidine
-
Scottsdale, Arizona
- +2 more
Nov 16, 2017